Abstract

Zonisamide (ZNS) is an anticonvulsant drug known to affect various neuronal channels and transmitter systems. ZNS has also been reported to inhibit carbonic anhydrase activity and may thus influence neuronal activity via changes of pH. Therefore, we analyzed effects of ZNS in vitro using epileptic model systems which are sensitive to carbonic anhydrase inhibition and pH changes. Intracellular recordings from CA3 neurons (hippocampal slice, adult guinea pigs) were carried out under bicarbonate-buffered conditions. Epileptiform activity was induced by either 4-aminopyridine or theophylline. In parallel experiments, intracellular pH (pHi) was determined in the CA1 and CA3 subfields of 2',7-bis(2-carboxyethyl)-5(6)-carboxyfluorescin-acetoxymethyl ether (BCECF-AM) loaded slices. The ammonium prepulse method was used to test for effects of ZNS on pHi regulation. ZNS (50 microM) reversibly reduced the frequency of 4-AP induced epileptiform bursting and the number of action potentials per bursts but had no effect on input resistance and membrane potential. Theophylline-induced epileptiform bursting, although sensitive to hypercapnic acidosis, was not affected by ZNS. There was also no effect on steady-state pHi and pHi regulation of BCECF-AM loaded hippocampal tissue. Clinically relevant concentrations of ZNS strongly inhibit 4-AP induced epileptiform activity of hippocampal CA3 neurons in vitro, but this effect was unlikely based on carbonic anhydrase inhibition or changes of neuronal pHi.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.